Adverse Events of Over-Immunosuppression Are Dependent on Tofacitinib Exposure in Kidney Transplant (KT) Patients. Busque, S., Vincenti, F., Tedesco Silva, H., O'Connell, P., Tortorici, M., Lawendy, N., Wang, W., Chan, G. WILEY-BLACKWELL. 2013: 86

View details for Web of Science ID 000318240300182